Cleared Traditional

K252160 - Persyst 15 EEG Review and Analysis Software (Persyst 15 (P15)) (FDA 510(k) Clearance)

Oct 2025
Decision
113d
Days
Class 2
Risk

K252160 is an FDA 510(k) clearance for the Persyst 15 EEG Review and Analysis Software (Persyst 15 (P15)). This device is classified as a Automatic Event Detection Software For Full-montage Electroencephalograph (Class II - Special Controls, product code OMB).

Submitted by Persyst Development, LLC (Solana Beach, US). The FDA issued a Cleared decision on October 31, 2025, 113 days after receiving the submission on July 10, 2025.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1400. Automatically Mark Or Identify Electroencephalograph Waveforms For Spikes, Electrographic Seizures, Seizure-like Events In Order To Aid In Identification Of Such Events And Help Review And Annotation Of Prolonged Eeg Traces; All Output Subject To Verification By Qualified User.

Submission Details

510(k) Number K252160 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 10, 2025
Decision Date October 31, 2025
Days to Decision 113 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement

Device Classification

Product Code OMB - Automatic Event Detection Software For Full-montage Electroencephalograph
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Automatically Mark Or Identify Electroencephalograph Waveforms For Spikes, Electrographic Seizures, Seizure-like Events In Order To Aid In Identification Of Such Events And Help Review And Annotation Of Prolonged Eeg Traces; All Output Subject To Verification By Qualified User